FitLife Brands (FTLF) Competitors

FitLife Brands (NASDAQ:FTLF) and Terns Pharmaceuticals (NASDAQ:TERN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends.

Is FTLF or TERN more profitable?

FitLife Brands has a net margin of 13.38% compared to Terns Pharmaceuticals' net margin of 0.00%. FitLife Brands' return on equity of 28.03% beat Terns Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FitLife Brands	13.38%	28.03%	15.13%
Terns Pharmaceuticals	N/A	-32.76%	-31.33%

Do analysts prefer FTLF or TERN?

FitLife Brands currently has a consensus price target of $40.00, suggesting a potential upside of 27.23%. Terns Pharmaceuticals has a consensus price target of $18.30, suggesting a potential upside of 212.29%. Given Terns Pharmaceuticals' higher probable upside, analysts plainly believe Terns Pharmaceuticals is more favorable than FitLife Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FitLife Brands	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.50
Terns Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80

Which has stronger earnings & valuation, FTLF or TERN?

FitLife Brands has higher revenue and earnings than Terns Pharmaceuticals. Terns Pharmaceuticals is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FitLife Brands	$62.76M	2.30	$5.30M	$1.69	18.60
Terns Pharmaceuticals	$1M	497.74	-$90.21M	-$1.18	-4.97

Does the MarketBeat Community favor FTLF or TERN?

Terns Pharmaceuticals received 40 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 60.87% of users gave Terns Pharmaceuticals an outperform vote while only 50.00% of users gave FitLife Brands an outperform vote.

Company	Underperform	Outperform
FitLife Brands	Outperform Votes 2 50.00%	Underperform Votes 2 50.00%
Terns Pharmaceuticals	Outperform Votes 42 60.87%	Underperform Votes 27 39.13%

Do insiders & institutionals have more ownership in FTLF or TERN?

2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 98.3% of Terns Pharmaceuticals shares are held by institutional investors. 61.3% of FitLife Brands shares are held by insiders. Comparatively, 15.1% of Terns Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Which has more risk & volatility, FTLF or TERN?

FitLife Brands has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500. Comparatively, Terns Pharmaceuticals has a beta of -0.36, suggesting that its stock price is 136% less volatile than the S&P 500.

Does the media refer more to FTLF or TERN?

In the previous week, Terns Pharmaceuticals had 2 more articles in the media than FitLife Brands. MarketBeat recorded 3 mentions for Terns Pharmaceuticals and 1 mentions for FitLife Brands. Terns Pharmaceuticals' average media sentiment score of 1.38 beat FitLife Brands' score of 0.95 indicating that Terns Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
FitLife Brands	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Terns Pharmaceuticals	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

FitLife Brands beats Terns Pharmaceuticals on 11 of the 19 factors compared between the two stocks.